Suchergebnisse - "Karen T. Liby"

PubPharm (19)

1

in: International Journal of Molecular Sciences | 2024

von Christopher J. Occhiuto | Karen T. Liby

2

The Triterpenoid CDDO-Methyl Ester Redirects Macrophage Polarization and Reduces Lung Tumor Burden in a Nrf2-Dependent Manner

in: Antioxidants | 2023

von Jessica A. Moerland | Ana S. Leal | Beth Lockwood | +4

3

The Novel RXR Agonist MSU-42011 Differentially Regulates Gene Expression in Mammary Tumors of MMTV-Neu Mice

in: International Journal of Molecular Sciences | 2023

von Lyndsey A. Reich | Ana S. Leal | Edmund Ellsworth | +1

4

T Cells and CDDO-Me Attenuate Immunosuppressive Activation of Human Melanoma-Conditioned Macrophages

in: Frontiers in Immunology | 2022

von Gretel M. Torres | Heetaek Yang | Chanhyuk Park | +5

5

The rexinoid V-125 reduces tumor growth in preclinical models of breast and lung cancer

in: Scientific Reports | 2022

von Lyndsey A. Reich | Jessica A. Moerland | Ana S. Leal | +7

6

Sustained, local delivery of the PARP inhibitor talazoparib prevents the development of mammary gland hyperplasia in Brca1-deficient mice

in: Scientific Reports | 2021

von Di Zhang | Bijay Singh | Jessica Moerland | +5

7

The RXR Agonist MSU42011 Is Effective for the Treatment of Preclinical HER2+ Breast Cancer and Kras-Driven Lung Cancer

in: Cancers | 2021

von Ana S. Leal | Jessica A. Moerland | Di Zhang | +6

8

The Bromodomain Inhibitor, INCB057643, Targets Both Cancer Cells and the Tumor Microenvironment in Two Preclinical Models of Pancreatic Cancer

in: Cancers | 2020

von Ana S. Leal | Phillip Liu | Teresa Krieger-Burke | +2

9

The novel rexinoid MSU-42011 is effective for the treatment of preclinical Kras-driven lung cancer

in: Scientific Reports | 2020

von Jessica A. Moerland | Di Zhang | Lyndsey A. Reich | +7

10

Identifying chemopreventive agents for obesity-associated cancers using an efficient, 3D high-throughput transformation assay

in: Scientific Reports | 2019

von Vanessa Benham | Blair Bullard | Thomas S. Dexheimer | +4